FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989820281> ?p ?o ?g. }

• W2989820281 abstract "Bioreducible antitumour agents are prodrugs which are intended to be inactive in their own right, but are able to undergo metabolic reduction to produce toxic species which can damage biomolecules. This reduction may occur readily in solid tumours due to two factors which are unique to them, a) tumour hypoxia; and b) the expression of high levels of reductase enzymes. Each of these factors can promote specific cytotoxicity to the tumour and in principle could create a selective antitumour agent. A series of N-oxides of heterocyclic aliphatic amines was prepared for evaluation as bioreducible drugs. N-oxides (A) of cis- and trans-2,6-disubstituted N-methyl-piperidine were prepared with X equal to carbamate or halogen. The free bases were designed to be bifunctional alkylating agents via aziridine ion formation. The cis-isomer was synthesised by hydrogenation of a derivative of dipicolinic acid followed by reduction to produce the diol from which the leaving groups were attatched. The trans-isomer was synthesised by ring closure of a pimelic acid derivative with methylamine followed by acidic epimerisation, from which the diol was obtained and derivatised. In total, 22 mostly novel compounds were synthesised and tested against two human colon carcinoma cell lines, HT 29 and BE cells under oxic and hypoxic conditions. HT 29 cells produce high amounts of DT-diaphorase which is a reductase enzyme that favours a 2e- reduction pathway, whilst BE cells contains no DT-diaphorase. IC50 values were also measured for selected compounds. The results showed that the free bases are toxic against both cell lines and the N-oxides are nontoxic. This suggested that the mono-N-oxides were not reduced under hypoxic conditions which implies that the reduction potentials of the compounds are not in the correct range for cellular reductants. Bis-N-oxides (B) of 1,4-disubstituted piperazines were also prepared and 10 mainly novel compounds were synthesised and tested in the same biological systems. These N-oxides also did not give any evidence of being reduced under hypoxic conditions but did have reduced toxicity in comparison to the free bases. IC50 values were measured for these compounds and the values indicated that the free bases were up to 1000-fold more toxic than the corresponding bis-N-oxides. In attempts to modify the reduction potentials of the piperidine N-oxides, a series of bis-piperidine-bis-N-oxides (C) of varying carbon chain length were prepared by a general route by linking two methyl pipecolinate molecules with a selection of diacid chlorides followed by reduction and introduction of the X group. 20 predominantly novel compounds were prepared and evaluated for toxicity and selectivity. There was little evidence of hypoxic/oxic selectivity by the N-oxides although their toxicity was substantially reduced compared to the free bases. The toxicity of the free bases did seem affected by the length of the carbon chain, and the compounds with a four carbon chain were most toxic by several orders of magnitude. (C) Cobalt is known to form stable octahedral Co(III) complexes with a range of aliphatic amines and the reduction potentials of such complexes fall within an reduction results in release of the ligands and it has been suggested that this may be incorporated into the design of novel bioreducible antitumour agents. A range of diamines, triamines and tetraamines with alkylating functionality were synthesised and complexed to Co(III). The polyamines were formed by a general route starting with amino acids and using mixed anhydride methodology to attach the nitrogen mustard functionality. The amines were obtained as hydrochloride salts and IC50 values were obtained. All were reasonably toxic, the most toxic having IC50 values in the J, molar region. Five cobalt complexes, such as D, were isolated and tested for oxic/hypoxic selectivity, two of which had been synthesised before. Of these, two showed promising selectivity, exhibiting greater toxicity under hypoxic conditions than under oxic conditions, although further testing is required." @default.
• W2989820281 created "2019-12-05" @default.
• W2989820281 creator A5057392404 @default.
• W2989820281 date "1994-01-01" @default.
• W2989820281 modified "2023-09-26" @default.
• W2989820281 title "Synthesis and biological evaluation of novel anti-cancer agents" @default.
• W2989820281 hasPublicationYear "1994" @default.
• W2989820281 type Work @default.
• W2989820281 sameAs 2989820281 @default.
• W2989820281 citedByCount "0" @default.
• W2989820281 crossrefType "dissertation" @default.
• W2989820281 hasAuthorship W2989820281A5057392404 @default.
• W2989820281 hasConcept C109316439 @default.
• W2989820281 hasConcept C181199279 @default.
• W2989820281 hasConcept C185592680 @default.
• W2989820281 hasConcept C202751555 @default.
• W2989820281 hasConcept C21951064 @default.
• W2989820281 hasConcept C2778969155 @default.
• W2989820281 hasConcept C55493867 @default.
• W2989820281 hasConcept C71240020 @default.
• W2989820281 hasConceptScore W2989820281C109316439 @default.
• W2989820281 hasConceptScore W2989820281C181199279 @default.
• W2989820281 hasConceptScore W2989820281C185592680 @default.
• W2989820281 hasConceptScore W2989820281C202751555 @default.
• W2989820281 hasConceptScore W2989820281C21951064 @default.
• W2989820281 hasConceptScore W2989820281C2778969155 @default.
• W2989820281 hasConceptScore W2989820281C55493867 @default.
• W2989820281 hasConceptScore W2989820281C71240020 @default.
• W2989820281 hasLocation W29898202811 @default.
• W2989820281 hasOpenAccess W2989820281 @default.
• W2989820281 hasPrimaryLocation W29898202811 @default.
• W2989820281 hasRelatedWork W1521334626 @default.
• W2989820281 hasRelatedWork W1960903705 @default.
• W2989820281 hasRelatedWork W2010804854 @default.
• W2989820281 hasRelatedWork W2035725728 @default.
• W2989820281 hasRelatedWork W2081876939 @default.
• W2989820281 hasRelatedWork W2087353276 @default.
• W2989820281 hasRelatedWork W2132382515 @default.
• W2989820281 hasRelatedWork W2143772777 @default.
• W2989820281 hasRelatedWork W2361261049 @default.
• W2989820281 hasRelatedWork W2361279202 @default.
• W2989820281 hasRelatedWork W2381769273 @default.
• W2989820281 hasRelatedWork W2402321678 @default.
• W2989820281 hasRelatedWork W2415049310 @default.
• W2989820281 hasRelatedWork W2416922116 @default.
• W2989820281 hasRelatedWork W2898668825 @default.
• W2989820281 hasRelatedWork W2951795609 @default.
• W2989820281 hasRelatedWork W2952984431 @default.
• W2989820281 hasRelatedWork W3028290747 @default.
• W2989820281 hasRelatedWork W2253987256 @default.
• W2989820281 hasRelatedWork W2934606467 @default.
• W2989820281 isParatext "false" @default.
• W2989820281 isRetracted "false" @default.
• W2989820281 magId "2989820281" @default.
• W2989820281 workType "dissertation" @default.